Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 25, 2026 20:31 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 335 | $13.97 | $4,679.95 |
DisclosureSEC source: 0001855616-26-000024 · wk-form4_1790368295.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,357 F1 · shares: Represents the number of shares withheld by the Issuer on September 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on September 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| September 20, 2026 Filed Sep 21, 2026 20:56 UTC |
Williams Patrick F.Chief Financial Officer
|
Tax withholdingCommon Stock | 1,162 | $14.28 | $16,593.36 |
DisclosureSEC source: 0001562229-26-000005 · wk-form4_1790024175.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,508 F1 · shares: Represents the number of shares withheld by the Issuer on September 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on September 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 21:42 UTC |
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 1,310 | $14.75 | $19,322.50 |
DisclosureSEC source: 0001533175-26-000016 · wk-form4_1788558148.xml · nonDerivative · entry 1 Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,000 F1 · shares: 1. Represents the number of shares withheld by the Issuer on September 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: 1. Represents the number of shares withheld by the Issuer on September 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| August 27, 2026 Filed Aug 28, 2026 17:03 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 358 | $14.13 | $5,058.54 |
DisclosureSEC source: 0001855616-26-000022 · wk-form4_1787950985.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,692 F1 · shares: Represents the number of shares withheld by the Issuer on August 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on August 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| August 27, 2026 Filed Aug 28, 2026 17:04 UTC |
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 1,126 | $14.13 | $15,910.38 |
DisclosureSEC source: 0001533175-26-000014 · wk-form4_1787951045.xml · nonDerivative · entry 1 Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,310 F1 · shares: Represents the number of shares withheld by the Issuer on August 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on August 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 20:12 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 335 | $16.22 | $5,433.70 |
DisclosureSEC source: 0001855616-26-000019 · wk-form4_1782418320.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,050 F1 · shares: Represents the number of shares withheld by the Issuer on June 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on June 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| June 19, 2026 Filed Jun 22, 2026 20:34 UTC |
Geiger UriDirector
|
GrantCommon Stock | 789 | $15.63 | $12,332.07 |
DisclosureSEC source: 0001467361-26-000005 · wk-form4_1782160441.xml · nonDerivative · entry 1 Geiger Uri · CIK 0001467361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,537 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| June 19, 2026 Filed Jun 22, 2026 20:33 UTC |
Fischer Frank MDirector
|
GrantCommon Stock | 1,467 | $15.63 | $22,929.21 |
DisclosureSEC source: 0001297260-26-000007 · wk-form4_1782160401.xml · nonDerivative · entry 1 Fischer Frank M · CIK 0001297260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 599,534 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| June 19, 2026 Filed Jun 22, 2026 20:32 UTC |
Kumar RakhiDirector
|
GrantCommon Stock | 989 | $15.63 | $15,458.07 |
DisclosureSEC source: 0001856296-26-000007 · wk-form4_1782160357.xml · nonDerivative · entry 1 Kumar Rakhi · CIK 0001856296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,039 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:09 UTC |
Ryan ReneeDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,368 | $0.00 Strike: $15.74 | $0.00 |
DisclosureSEC source: 0001855576-26-000002 · wk-form4_1780693777.xml · derivative · entry 2 Ryan Renee · CIK 0001855576 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,368 Underlying: Common Stock · 5,368 shares Expires 2036-06-04 F2 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:09 UTC |
Ryan ReneeDirector
|
GrantCommon Stock | 2,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001855576-26-000002 · wk-form4_1780693777.xml · nonDerivative · entry 1 Ryan Renee · CIK 0001855576 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,890 F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:10 UTC |
Geiger UriDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,368 | $0.00 Strike: $15.74 | $0.00 |
DisclosureSEC source: 0001467361-26-000003 · wk-form4_1780693831.xml · derivative · entry 3 Geiger Uri · CIK 0001467361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,368 Underlying: Common Stock · 5,368 shares Expires 2036-06-04 F3 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:10 UTC |
Geiger UriDirector
|
GrantCommon Stock | 2,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001467361-26-000003 · wk-form4_1780693831.xml · nonDerivative · entry 1 Geiger Uri · CIK 0001467361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,748 F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:10 UTC |
Fischer Frank MDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,368 | $0.00 Strike: $15.74 | $0.00 |
DisclosureSEC source: 0001297260-26-000005 · wk-form4_1780693848.xml · derivative · entry 2 Fischer Frank M · CIK 0001297260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,368 Underlying: Common Stock · 5,368 shares Expires 2036-06-04 F2 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:10 UTC |
Fischer Frank MDirector
|
GrantCommon Stock | 2,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001297260-26-000005 · wk-form4_1780693848.xml · nonDerivative · entry 1 Fischer Frank M · CIK 0001297260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 598,067 F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:13 UTC |
Huennekens R ScottDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,368 | $0.00 Strike: $15.74 | $0.00 |
DisclosureSEC source: 0001628280-26-041324 · wk-form4_1780694002.xml · derivative · entry 2 Huennekens R Scott · CIK 0001365493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,368 Underlying: Common Stock · 5,368 shares Expires 2036-06-04 F2 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:13 UTC |
Huennekens R ScottDirector
|
GrantCommon Stock | 2,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041324 · wk-form4_1780694002.xml · nonDerivative · entry 1 Huennekens R Scott · CIK 0001365493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,890 F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:10 UTC |
Kumar RakhiDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,368 | $0.00 Strike: $15.74 | $0.00 |
DisclosureSEC source: 0001856296-26-000005 · wk-form4_1780693812.xml · derivative · entry 2 Kumar Rakhi · CIK 0001856296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,368 Underlying: Common Stock · 5,368 shares Expires 2036-06-04 F2 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:10 UTC |
Kumar RakhiDirector
|
GrantCommon Stock | 2,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001856296-26-000005 · wk-form4_1780693812.xml · nonDerivative · entry 1 Kumar Rakhi · CIK 0001856296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,050 F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:09 UTC |
Andrade LisaDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,368 | $0.00 Strike: $15.74 | $0.00 |
DisclosureSEC source: 0001595202-26-000002 · wk-form4_1780693739.xml · derivative · entry 2 Andrade Lisa · CIK 0001595202 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,368 Underlying: Common Stock · 5,368 shares Expires 2036-06-04 F2 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 05, 2026 Filed Jun 5, 2026 21:09 UTC |
Andrade LisaDirector
|
GrantCommon Stock | 2,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001595202-26-000002 · wk-form4_1780693739.xml · nonDerivative · entry 1 Andrade Lisa · CIK 0001595202 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,890 F1 · shares: The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:03 UTC |
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 1,255 | $15.88 | $19,929.40 |
DisclosureSEC source: 0001533175-26-000011 · wk-form4_1780603384.xml · nonDerivative · entry 1 Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,436 F1 · shares: Represents the number of shares withheld by the Issuer on June 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on June 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| May 27, 2026 Filed May 28, 2026 20:40 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 358 | $17.06 | $6,107.48 |
DisclosureSEC source: 0001855616-26-000017 · wk-form4_1780000834.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,385 F1 · shares: Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| May 27, 2026 Filed May 28, 2026 20:42 UTC |
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 1,126 | $17.06 | $19,209.56 |
DisclosureSEC source: 0001533175-26-000009 · wk-form4_1780000959.xml · nonDerivative · entry 1 Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,691 F1 · shares: Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:27 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 14,550 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0001855616-26-000015 · wk-form4_1779222436.xml · derivative · entry 2 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,550 Underlying: Common Stock · 14,550 shares Expires 2036-05-14 F2 · derivative.exercise_date: 25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:27 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
GrantCommon Stock | 5,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001855616-26-000015 · wk-form4_1779222436.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,743 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:51 UTC |
Williams Patrick F.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 44,800 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0001562229-26-000002 · form4-05192026_080535.xml · derivative · entry 2 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,800 Underlying: Common Stock · 44,800 shares Expires 2036-05-14 F2 · derivative.exercise_date: 25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:51 UTC |
Williams Patrick F.Chief Financial Officer
|
GrantCommon Stock | 16,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001562229-26-000002 · form4-05192026_080535.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,670 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:26 UTC |
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 122,190 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0001533175-26-000007 · wk-form4_1779222368.xml · derivative · entry 2 Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,190 Underlying: Common Stock · 122,190 shares Expires 2036-05-14 F2 · derivative.exercise_date: 25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:26 UTC |
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 45,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001533175-26-000007 · wk-form4_1779222368.xml · nonDerivative · entry 1 Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,817 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| March 24, 2026 Filed Mar 25, 2026 20:20 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 1,341 | $13.27 | $17,795.07 |
DisclosureSEC source: 0001855616-26-000011 · wk-form4_1774470047.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,283 F1 · shares: Represents the number of shares withheld by the Issuer on March 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on March 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 20:41 UTC |
Fischer Frank MDirector
|
GrantCommon Stock | 1,826 | $13.00 | $23,738.00 |
DisclosureSEC source: 0001297260-26-000003 · wk-form4_1774298494.xml · nonDerivative · entry 1 Fischer Frank M · CIK 0001297260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 595,177 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| March 20, 2026 Filed Mar 23, 2026 20:42 UTC |
Kumar RakhiDirector
|
GrantCommon Stock | 1,153 | $13.00 | $14,989.00 |
DisclosureSEC source: 0001856296-26-000003 · wk-form4_1774298557.xml · nonDerivative · entry 1 Kumar Rakhi · CIK 0001856296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,160 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:47 UTC |
Geiger UriDirector
|
GrantCommon Stock | 913 | $13.00 | $11,869.00 |
DisclosureSEC source: 0001628280-26-020837 · wk-form4_1774385234.xml · nonDerivative · entry 1 Geiger Uri · CIK 0001467361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,858 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:45 UTC |
LACOB JOSEPHDirector
|
GrantCommon Stock | 865 | $13.00 | $11,245.00 |
DisclosureSEC source: 0001628280-26-020835 · wk-form4_1774385141.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,754 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:43 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 1,340 | $13.83 | $18,532.20 |
DisclosureSEC source: 0001855616-26-000007 · wk-form4_1772660606.xml · nonDerivative · entry 2 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,624 F3 · shares: Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:41 UTC |
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 5,023 | $13.83 | $69,468.09 |
DisclosureSEC source: 0001533175-26-000004 · wk-form4_1772660493.xml · nonDerivative · entry 1 Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,937 F1 · shares: Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 17:51 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 358 | $14.58 | $5,219.64 |
DisclosureSEC source: 0001855616-26-000005 · wk-form4_1772473884.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,964 F1 · shares: Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 21:46 UTC |
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 1,126 | $14.58 | $16,417.08 |
DisclosureSEC source: 0001533175-26-000002 · wk-form4_1772487987.xml · nonDerivative · entry 1 Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,960 F1 · shares: Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 22:31 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 3,412 | $14.34 | $48,928.08 |
DisclosureSEC source: 0001855616-26-000003 · wk-form4_1771885895.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,322 F1 · shares: Represents the number of shares withheld by the Issuer on February 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. F1 · price: Represents the number of shares withheld by the Issuer on February 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| December 19, 2025 Filed Dec 23, 2025 21:15 UTC |
Geiger UriDirector
|
GrantCommon Stock | 715 | $16.59 | $11,861.85 |
DisclosureSEC source: 0001467361-25-000005 · form4-12232025_041220.xml · nonDerivative · entry 1 Geiger Uri · CIK 0001467361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,945 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| December 19, 2025 Filed Dec 23, 2025 21:15 UTC |
Fischer Frank MDirector
|
GrantCommon Stock | 1,431 | $16.59 | $23,740.29 |
DisclosureSEC source: 0001297260-25-000006 · form4-12232025_041217.xml · nonDerivative · entry 1 Fischer Frank M · CIK 0001297260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 593,351 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| December 19, 2025 Filed Dec 23, 2025 21:15 UTC |
LACOB JOSEPHDirector
|
GrantCommon Stock | 678 | $16.59 | $11,248.02 |
DisclosureSEC source: 0001215490-25-000007 · form4-12232025_041223.xml · nonDerivative · entry 1 LACOB JOSEPH · CIK 0001215490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,889 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| December 19, 2025 Filed Dec 23, 2025 21:15 UTC |
Kumar RakhiDirector
|
GrantCommon Stock | 904 | $16.59 | $14,997.36 |
DisclosureSEC source: 0001856296-25-000005 · form4-12232025_041221.xml · nonDerivative · entry 1 Kumar Rakhi · CIK 0001856296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,007 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
| December 15, 2025 Filed Mar 4, 2026 21:43 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 25,000 | $15.97 | $399,250.00 |
DisclosureSEC source: 0001855616-26-000007 · wk-form4_1772660606.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,964 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.26, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 21:30 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 1,338 | $16.66 | $22,291.08 |
DisclosureSEC source: 0001855616-25-000007 · form4-12042025_041201.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,734 F1 · shares: Represents the number of shares withheld by the Issuer on December 3, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| November 27, 2025 Filed Dec 1, 2025 21:15 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 357 | $16.50 | $5,890.50 |
DisclosureSEC source: 0001855616-25-000005 · form4-12012025_041201.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,072 F1 · shares: Represents the number of shares withheld by the Issuer on November 27, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| November 27, 2025 Filed Dec 1, 2025 21:15 UTC |
Becker JoelDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 1,126 | $16.50 | $18,579.00 |
DisclosureSEC source: 0001533175-25-000004 · form4-12012025_041203.xml · nonDerivative · entry 1 Becker Joel · CIK 0001533175 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,086 F1 · shares: Represents the number of shares withheld by the Issuer on November 27, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:57 UTC |
Morrell MarthaCHIEF MEDICAL OFFICER
|
Tax withholdingCommon Stock | 3,051 | $13.50 | $41,188.50 |
DisclosureSEC source: 0001855616-25-000003 · form4-11242025_091103.xml · nonDerivative · entry 1 Morrell Martha · CIK 0001855616 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,429 F1 · shares: Represents the number of shares withheld by the Issuer on November 20, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. Read SEC document |
| September 19, 2025 Filed Sep 22, 2025 23:30 UTC |
Geiger UriDirector
|
GrantCommon Stock | 1,194 | $9.94 | $11,868.36 |
DisclosureSEC source: 0001467361-25-000003 · form4-09222025_070908.xml · nonDerivative · entry 1 Geiger Uri · CIK 0001467361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,230 F1 · shares: These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.